These observations provide the first genetic evidence showing that bradykinin is critical in the pathogenesis of CAIA and B1R is likely a key receptor that mediates the proinflammatory effect of bradykinin in arthritis. This evidence concerns the gene KNG1 and arthritic joint disease.